Ranbaxy pulled off skincare drug from UK

Gurgaon-based Ranbaxy Laboratories has reportedly pulled off fresh stock of Isotretinoin 20 mg capsules from the UK market following an order from the European Commission. Isotretinoin is used for treating severe skin conditions. According to a statement issued on the official website of the UK Medicines and Healthcare Products Regulatory Agency’s (MHRA), the company’s UK arm, Ranbaxy (UK) Ltd is recalling all unexpired stock of this product following a decision made by the European Commission that the marketing authorization should be suspended as a temporary measure, citing a possible issue with bioequivalence as the reason.